GB0313242D0 - Pulmonary immunopathology - Google Patents

Pulmonary immunopathology

Info

Publication number
GB0313242D0
GB0313242D0 GBGB0313242.0A GB0313242A GB0313242D0 GB 0313242 D0 GB0313242 D0 GB 0313242D0 GB 0313242 A GB0313242 A GB 0313242A GB 0313242 D0 GB0313242 D0 GB 0313242D0
Authority
GB
United Kingdom
Prior art keywords
pulmonary immunopathology
immunopathology
pulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0313242.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB0313242.0A priority Critical patent/GB0313242D0/en
Publication of GB0313242D0 publication Critical patent/GB0313242D0/en
Priority to PCT/GB2004/002333 priority patent/WO2004108154A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0313242.0A 2003-06-09 2003-06-09 Pulmonary immunopathology Ceased GB0313242D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0313242.0A GB0313242D0 (en) 2003-06-09 2003-06-09 Pulmonary immunopathology
PCT/GB2004/002333 WO2004108154A1 (en) 2003-06-09 2004-06-01 Prevention of pulmonary immunopathology using mutant bacterial toxins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0313242.0A GB0313242D0 (en) 2003-06-09 2003-06-09 Pulmonary immunopathology

Publications (1)

Publication Number Publication Date
GB0313242D0 true GB0313242D0 (en) 2003-07-16

Family

ID=27589711

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0313242.0A Ceased GB0313242D0 (en) 2003-06-09 2003-06-09 Pulmonary immunopathology

Country Status (2)

Country Link
GB (1) GB0313242D0 (en)
WO (1) WO2004108154A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102012003790A2 (en) * 2012-02-17 2014-04-22 Fundacao Butantan RECOMBINANT MYCOBACTERIUM CEPA, IMMUNOGENIC COMPOSITION AND USE
TWI811673B (en) 2020-05-08 2023-08-11 昱厚生技股份有限公司 Method for the prophylaxis or treatment of coronavirus infection using an immunomodulator and vaccine compositions comprising the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223334B (en) * 1987-11-02 1990-09-19 Sclavo Spa IMMUNOLOGICALLY ACTIVE POLYPEPTIDES WITH AN ALTERED TOXICITY USEFUL FOR THE PREPARATION OF AN ANTIPERTOX VACCINE
IT1253009B (en) * 1991-12-31 1995-07-10 Sclavo Ricerca S R L DETOXIFIED IMMUNOGENIC MUTANTS OF COLERIC TOXIN AND TOXIN LT, THEIR PREPARATION AND USE FOR THE PREPARATION OF VACCINES

Also Published As

Publication number Publication date
WO2004108154A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
JP2004006689A5 (en)
JP2003303134A5 (en)
JP2005537804A5 (en)
JP2004023096A5 (en)
JP2004046140A5 (en)
DE602004014122D1 (en)
IN2008CH00415A (en)
JP2003291036A5 (en)
JP2003331592A5 (en)
JP2004005449A5 (en)
IN246332B (en)
JP2003326870A5 (en)
JP2003264786A5 (en)
JP2003315102A5 (en)
JP2004007442A5 (en)
JP2004247898A5 (en)
JP2004276538A5 (en)
JP2004006815A5 (en)
EP1681004A4 (en) Cleaner
JP2004000473A5 (en)
JP2003270483A5 (en)
JP2004005398A5 (en)
JP2003271267A5 (en)
JP2004233796A5 (en)
JP2004002012A5 (en)

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)